The largest database of trusted experimental protocols

5 protocols using cd43 apc

1

Flow Cytometry Analysis of Erythroid Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
105 differentiating cells were harvested in phosphate‐buffered saline (PBS) containing 1% bovine serum albumin (BSA) (PBS/BSA) and centrifuged at 200 g for 5 minutes. Cell pellets were resuspended and mixed with the appropriate volume of antibody, CD34‐PE (12‐0349‐41, eBioscience, eBioscience Ltd., Hatfield, UK, http://www.ebioscience.com/), CD43‐APC (17‐0439‐42, eBioscience), CD235a‐FITC (11‐9987‐80, eBioscience), and CD71‐APC (17‐0719‐42, eBioscience), to a final volume of 100 μl PBS/BSA, incubated for 30 minutes then analyzed on a LSR Fortessa (BD Biosciences, Oxford, UK, http://www.bdbiosciences.com/) using FACS Diva. The proportion of enucleated cells present in the culture was assessed using CD235a‐FITC, CD71‐APC antibodies, LIVE/DEAD Fixable Near‐IR Stain (L10119, Thermo Fisher Scientific) and Hoechst dye (NucBlue, Thermo Fisher Scientific). Live CD235a+ cells were first gated, then anti‐CD71 and Hoeschst were used to define erythroblasts (CD71+/Hoechst+), nucleated RBCs (CD71/Hoechst+) and enucleated RBCs (CD71/Hoechst) (Supporting Information Fig. S7).
+ Open protocol
+ Expand
2

Multi-color Flow Cytometry Immune Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were stained immediately after thawing in FACS buffer (PBS with 0.1% NaN3 and 2% FBS; Lonza). Color compensations were done using a mix of cells and compensation beads (BD Biosciences). After incubation of the cells with antibodies on ice for 30 min, they were washed with FACS buffer. Hoechst (Invitrogen) live/dead marker was added shortly prior to measuring on a FACSAria SORP machine (BD Biosciences). The following antibodies were used in the panel: CD14-eFluor605NC, CD24-eF450, CD43-APC, CD23-APC-eFluor780 (eBioscience), IgD-BV421, CD19-BV605, IgG-PE (BD Pharmingen), CD10-BV510, CD138-BV711, CD27-PECF594 (BD Horizon), IgM-BV570, CD38-PerCP-Cy5.5, CD21-PE-Cy7, CD20-AF700 (BioLegend), CD5-FITC, CD3-PE-Dy647 (Immunotools).
+ Open protocol
+ Expand
3

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood was collected by facial vein bleed into EDTA Microtainer tubes (BD Biosciences, NJ) and CBC performed on a Heska Hematrue (Heska, CO). Flow cytometry was acquired on a FACSVerse (BD Biosciences, NJ) and analyzed using Flowjo (Flowjo, OR). Cell sorting was performed on an Astrios (Beckman Coulter). Antibodies were used from (1) BioXCell: Fc block (2.4G2), and (2) eBioscience: B220-APC-Cy7 (RA3–6B2), CD11c-APC (N418), CD138-PE-Cy7 (DL-101), CD19-APC (1D3), CD19-PE-Cy7 (1D3), CD21-FITC (4E3), CD23-PE (B3B4), CD25-APC (PC61.5), CD3-FITC (145–2C11), CD4-PE-Cy7 (RM4–5), CD43-APC (R2/60), CD44-PE (IM7), CD45.1-PE (A20), CD45.2-APC (104), CD5-APC (53–7.3), CD62L-APC (MEL-14), CD8-APC-Cy7 (53–6.7), CD8-FITC (53–6.7), Foxp3-PE (FJK-16s), IFNγ-APC (XMG1.2), IgD-FITC (11–26c), IgM-PE (eB121–15F9), IL-17-APC (eBio1787), NK1.1-PB (PK136). Cell viability assessed using fixable Live/Dead Aqua dye (Invitrogen). Flow cytometry for LC3 was performed per manufacturer’s instructions (FlowCellect, Millipore).
+ Open protocol
+ Expand
4

Evaluating hPSC-Derived Cells by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate HE differentiation by flow cytometric analysis, hPSC-derived cells were dissociated by incubation in 0.1% collagenase for 2 h followed by TypLE Express for 8 min. Cells were mechanically dissociated and resuspended in 2% v/v FBS in Hank's buffered saline solution (HF). The following antibodies (obtained from BD Biosciences unless otherwise specified) were used at indicated dilutions: CD34-APC (1:100); CD144-PE (4:100); CD144-V450 (4:100); CD43-PE (3:100); CD45-PE-CY7 (4:100); CD4-PE (1:50) or CD34-PE (1:50); CD5-PE/Cy7 (1:200); CD7-AF700 (1:200); CD43-APC (1:200); CD45-APC/eF780 (1:200, eBiosciences); Ckit-APC (1:100); and PE-KDR (1:50). Control samples were prepared by incubating duplicate cell samples with respective fluorochome-labelled isotype antibodies. Samples were incubated with antibodies for 35 min on ice and then washed three times in cold HF. Viability discrimination was performed simultaneously using the viability stain 7-amino-actinomycin D at 1 μl ml−1 (Molecular Probes). Samples were analysed on a Becton Dickinson FACS Fortessa machine using BD FACS Diva Software. Cells were sorted using a FACS Aria (BD Bioscience) cell sorter (Donnelly Centre for Cellular & Biomolecular Research).
+ Open protocol
+ Expand
5

Flow Cytometry Analysis of Hematopoietic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were harvested, and 2 × 105 cells were placed in aliquots in phosphate-buffered saline (PBS) containing 1% BSA (PBS/BSA) and centrifuged (200g) for 5 minutes. Antibodies were added directly to cell pellets that were then resuspended to a final volume of 100 μl, incubated for 30 minutes on ice, washed in 5 ml PBS/BSA, and resuspended in 300 μl. The samples were analyzed using an LSRFortessa (BD Biosciences, Franklin Lakes, NJ, http://www.bdbiosciences.com) using FACSDiva acquisition (BD Biosciences) and FlowJo analysis software (FlowJo, Ashland, OR, http://www.flowjo.com), or sorted on a FACSARIA (BD Biosciences). Anti-human antibodies included CD71-FITC (catalog no. 11-0719; eBioscience, San Diego, CA, http://www.ebioscience.com), CD43-APC (catalog no. 17-0439-42; eBioscience), glycophorinA (M) (CD235a), efluor450 (catalog no. 48-9884; eBioscience), CD34-PE (catalog no. 12-0349; eBioscience), CD41a-FITC (BD Biosciences), CD45-V450 (BD Biosciences), and CD144-PE (Beckman Coulter, Brea, CA, http://www.beckmancoulter.com). Mouse IgG1 APC isotype control (catalog no. 17-4714-81; eBioscience) and mouse IgG1 PE isotype control (catalog no. 12-4714-81; eBioscience) were used (supplemental online Fig. 2).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!